Persistent Corneal Epithelial Defects Drugs Pipeline Landscape Report 2021 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Persistent Corneal Epithelial Defects (Ophthalmology) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com's offering. The report provides comprehensive information on the therapeutics under development for Persistent Corneal Epithelial Defects, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action

Full Story →